Ryder (R) reported earnings 30 days ago. What's next for the stock?

The TRUFORMA Platform now has the widest dynamic range (without manual dilution) available either at the Point of Care or from a Reference Lab ANN ARBOR, MI / ACCESS Newswire / May 21, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced an update to one of their fastest growing assays, insulin for equine plasma. This update increases the test's already industry-leading point of care dynamic range and adds a new function, automatic sample dilution, that allows a veterinarian to measure insulin at the highest levels with no additional steps or increase in time-to-result on the TRUFORMA In-Clinic Biosensor Testing Platform.

Promising results from the first-in-human study demonstrated that, at three-years post implantation, VenoValve remained safe and effective--achieving a high rate of patency, restoring deep venous competence and maintaining clinical benefits Company has submitted PMA application for the VenoValve to the U.S. Food and Drug Administration (FDA) with a decision anticipated in the second half of 2025 IRVINE, CA / ACCESS Newswire / May 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that its manuscript titled, " Three-Year Outcomes of Surgical Implantation of a Novel Bioprosthetic Valve for the Treatment of Deep Venous Reflux 1," has been published in the in the peer-reviewed journal, Annals of Vascular Surgery. The VenoValve was surgically implanted in the femoral vein of eleven subjects with active or healed venous ulcers (CEAP classifications C5-C6).

Innovative Registry Harnesses Shock Wave Therapy to Advance Non-Drug Equine Asthma Treatment and Drive Evidence-Based Veterinary Care ANN ARBOR, MI / ACCESS Newswire / May 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Equine Asthma Clinical Registry. This pioneering program leverages PulseVet® shock wave therapy to offer a non-invasive, drug-free treatment alternative for horses suffering from asthma.

Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Kuwait-based Dream Water® brand distributor is launching the Company's new 60-Count Sleep Gummies in Middle Eastern markets. The Company's 60-Count Sleep Gummies are expected to be available in the distributor's local markets by July 2025.

$32B Global IT Services Analyst, Gartner (IT), Provides Guidance on Digital Twins Use Cases Arlington, Virginia--(Newsfile Corp. - May 8, 2025) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5I) ("edgeTI", "Company"), a leading provider of real-time digital twin software, announces the Company was Recognized by Gartner® (NYSE: IT) in its Gartner Hype Cycle™ for Power and Utility IT, 2024 as a Sample Vendor in the Digital Twins category. The report states, "To ensure the continued provision of affordable and sustainable services, power and utilities companies must transform with digital technology.

MIAMI--(BUSINESS WIRE)-- #RyderEverbetter--The Board of Directors of Ryder System, Inc. (NYSE: R) declared a regular quarterly cash dividend of $0.81 per share of common stock to be paid on June 20, 2025, to shareholders of record on May 19, 2025. This is Ryder's 195th consecutive quarterly cash dividend – marking more than 48 years of uninterrupted dividend payments. About Ryder System, Inc. Ryder System, Inc. (NYSE: R) is a fully integrated port-to-door logistics and transportation company. It provides supply c.

R's first-quarter 2025 revenues benefit from the prior-year acquisition and contractual revenue growth in Supply Chain Solutions and Fleet Management Solutions.

Ryder System, Inc. (NYSE:R ) Q1 2025 Earnings Conference Call April 23, 2025 11:00 AM ET Company Participants Calene Candela - Vice President, Investor Relations Robert Sanchez - Chairman and Chief Executive Officer Cristina Gallo-Aquino - Executive Vice President and Chief Financial Officer John Diez - President and Chief Operating Officer Tom Havens - President, Fleet Management Solutions Steve Sensing - President, Supply Chain Solutions and Dedicated Transportation Solutions Conference Call Participants Jordan Alliger - Goldman Sachs Christyne McGarvey - Morgan Stanley Jeff Kauffman - Vertical Research Partners Scott Group - Wolfe Research Reed Seay - Stephens Inc. Brian Ossenbeck - JPMorgan Harrison Bauer - Susquehanna Operator Good morning, and welcome to the Ryder System First Quarter 2025 Earnings Release Conference Call. All lines are in listen-only mode, until after the presentation.

While the top- and bottom-line numbers for Ryder (R) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.